Curanex Pharmaceuticals Sets CFO Compensation at $20,000 Per Year
I'm PortAI, I can summarize articles.
Curanex Pharmaceuticals Inc. has appointed Wanjun Zhang as the new CFO and Treasurer, effective January 1, 2026, following Haiyan Yang's resignation. Zhang will receive an annual compensation of $20,000 under a two-year consulting agreement. This announcement was published via EDGAR by the U.S. SEC.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments